Historical shareholding details of BlackRock Health Sciences Term Trust holdings in 4D Molecular Therapeutics Inc (FDMT)

Monthly changes of BlackRock Health Sciences Term Trust shareholding in 4D Molecular Therapeutics Inc over the previous months

Month Name Total no. shares held Percent Holding
Jun 30, 2025 Blackrock Health Sciences Term Trust 63,685 0.14%
Mar 31, 2025 Blackrock Health Sciences Term Trust 109,215 0.23%
Dec 31, 2024 Blackrock Health Sciences Term Trust 109,215 0.24%
Sep 30, 2024 Blackrock Health Sciences Term Trust 109,215 0.24%
Aug 31, 2024 Blackrock Health Sciences Term Trust 109,215 0.24%
Jul 31, 2024 Blackrock Health Sciences Term Trust 109,215 0.21%
Jun 30, 2024 Blackrock Health Sciences Term Trust 146,438 0.28%
May 31, 2024 Blackrock Health Sciences Term Trust 146,438 0.28%
Apr 30, 2024 Blackrock Health Sciences Term Trust 146,438 0.28%
Mar 31, 2024 Blackrock Health Sciences Term Trust 146,438 0.29%
Feb 29, 2024 Blackrock Health Sciences Term Trust 146,438 0.29%
Jan 31, 2024 Blackrock Health Sciences Term Trust 95,330 0.19%
Dec 31, 2023 Blackrock Health Sciences Term Trust 95,330 0.22%
Nov 30, 2023 Blackrock Health Sciences Term Trust 95,330 0.22%
Oct 31, 2023 Blackrock Health Sciences Term Trust 95,330 0.22%
Sep 30, 2023 Blackrock Health Sciences Term Trust 95,330 0.23%
Aug 31, 2023 Blackrock Health Sciences Term Trust 95,330 0.23%
Jul 31, 2023 Blackrock Health Sciences Term Trust 95,330 0.23%
Jun 30, 2023 Blackrock Health Sciences Term Trust 95,330 0.23%
May 31, 2023 Blackrock Health Sciences Term Trust 95,330 0.23%
Apr 30, 2023 Blackrock Health Sciences Term Trust 95,330 0.23%

View all ownership details of 4D Molecular Therapeutics Inc